Health ProductsType I recall

APO-AMITRIPTYLINE 10mg: NDMA Impurity

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: APO-AMITRIPTYLINE 10mg
Issue: Health products - Contamination, Health products - Product safety
What to do: Patients can continue to take their medication as prescribed by their health care provider as there is no immediate risk in continuing to take the recalled medication. Contact your health care provider if you have taken a recalled product and you have concerns about your health.
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandLotProduct NameMarket AuthorizationDosage FormStrength
APO-AMITRIPTYLINEPY1904APO-AMITRIPTYLINEDIN 02403137Tablet10 MG

Issue

Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 48-month stability testing timepoint.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime